These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 28847684)

  • 1. Faecal zonulin, calprotectin and the infant microbiome in early life.
    Bacorn M; Subramanian P; Levy S; Chen Q; Maxwell GL; Hourigan SK
    Clin Transl Med; 2024 May; 14(5):e1695. PubMed ID: 38773685
    [No Abstract]   [Full Text] [Related]  

  • 2. Calprotectin as a companion biomarker for colorectal cancer: A lesson from microscopic bowel inflammation.
    Chang CH; Lee WK; Chou MC; Ho HW; Lin HY
    Int J Rheum Dis; 2023 Aug; 26(8):1643-1644. PubMed ID: 36973068
    [No Abstract]   [Full Text] [Related]  

  • 3. Stability of fecal calprotectin extracts using the Diasorin
    Billet B; Choisnard L; Faure P; Guicherd D; Cussigh E; Peyrin E; Ravelet C; Chovelon B
    Clin Chem Lab Med; 2024 Jan; 62(1):e13-e15. PubMed ID: 37470268
    [No Abstract]   [Full Text] [Related]  

  • 4. Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases.
    Kapel N; Ouni H; Benahmed NA; Barbot-Trystram L
    Clin Transl Gastroenterol; 2023 Sep; 14(9):e00617. PubMed ID: 37440723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Faecal Calprotectin Assay by IDS: Validation and Comparison to DiaSorin Method.
    Castiglione V; Berodes M; Lukas P; Louis E; Cavalier E; Lutteri L
    Diagnostics (Basel); 2022 Sep; 12(10):. PubMed ID: 36292026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease.
    Guo X; Huang C; Xu J; Xu H; Liu L; Zhao H; Wang J; Huang W; Peng W; Chen Y; Nie Y; Zhou Y; Zhou Y
    Front Nutr; 2021; 8():818902. PubMed ID: 35127797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International consensus on methodological issues in standardization of fecal calprotectin measurement in inflammatory bowel diseases.
    D'Amico F; Rubin DT; Kotze PG; Magro F; Siegmund B; Kobayashi T; Olivera PA; Bossuyt P; Pouillon L; Louis E; Domènech E; Ghosh S; Danese S; Peyrin-Biroulet L
    United European Gastroenterol J; 2021 May; 9(4):451-460. PubMed ID: 33961734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calprotectin in inflammatory bowel disease.
    Khaki-Khatibi F; Qujeq D; Kashifard M; Moein S; Maniati M; Vaghari-Tabari M
    Clin Chim Acta; 2020 Nov; 510():556-565. PubMed ID: 32818491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Faecal calprotectin determination: impact of preanalytical sample treatment and stool consistency on within- and between-method variability.
    Juricic G; Brencic T; Tesija-Kuna A; Njegovan M; Honovic L
    Biochem Med (Zagreb); 2019 Feb; 29(1):010707. PubMed ID: 30799976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Faecal calprotectin is a useful biomarker for intestinal inflammation].
    Theede K; Kiszka-Kanowitz M; Nordgaard-Lassen I; Nielsen AM
    Ugeskr Laeger; 2014 Sep; 176(37):. PubMed ID: 25294035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
    Gisbert JP; McNicholl AG
    Dig Liver Dis; 2009 Jan; 41(1):56-66. PubMed ID: 18602356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do not forget about pre-analytics in faecal calprotectin measurement!
    Oyaert M; Van den Bremt S; Boel A; Bossuyt X; Van Hoovels L
    Clin Chim Acta; 2017 Oct; 473():124-126. PubMed ID: 28847684
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of two immunoassays for measurement of faecal calprotectin in detection of inflammatory bowel disease: (pre)-analytical and diagnostic performance characteristics.
    Oyaert M; Trouvé C; Baert F; De Smet D; Langlois M; Vanpoucke H
    Clin Chem Lab Med; 2014 Mar; 52(3):391-7. PubMed ID: 24114912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal calprotectin for the diagnosis of inflammatory bowel disease.
    Logan R
    BMJ; 2010 Jul; 341():c3636. PubMed ID: 20634348
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated Faecal Calprotectin Does Not Differentiate Between Inflammatory Bowel Disease and a Juvenile Polyp.
    Zijlstra M; Pluimakers V; Nikkels P; Wolters V; Houwen R
    J Pediatr Gastroenterol Nutr; 2016 Feb; 62(2):e22-3. PubMed ID: 26799281
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.